Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high prices ...
Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March ...
Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...
Lawsuit alleges a 2019 settlement delayed Teva's generic Victoza launch, with plaintiffs seeking unspecified monetary damages ...
Health care workers are changing how they counsel patients. Experts are using our database to support their research. And ...
The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...
The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely watched for its implications for the availability of generic medicines.
U.S. District Judge Cynthia Rufe of the Eastern District of Pennsylvania granted final approval of a $200 million settlement between end-payer plaintiffs and Sun Pharmaceutical Industries and Taro ...
The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.
By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results